SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-13-339935
Filing Date
2013-08-20
Accepted
2013-08-19 19:38:23
Documents
4
Effectiveness Date
2013-08-20

Document Format Files

Seq Description Document Type Size
1 S-8 POS d550963ds8pos.htm S-8 POS 64306
2 EX-5.1 d550963dex51.htm EX-5.1 12774
3 GRAPHIC g550963g10f27.jpg GRAPHIC 4368
4 GRAPHIC g550963g33p05.jpg GRAPHIC 2586
  Complete submission text file 0001193125-13-339935.txt   88260
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-101826 | Film No.: 131049409
SIC: 2834 Pharmaceutical Preparations